- Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A
-
Ray D, Kumar N, Hans C, Kler A, Jain R, Bansal D, Trehan A, Jain A, Malhotra P, Ahluwalia J
- KMID: 2541066
- Blood Res.
- 2023 Mar;58(1):61-70.
- doi: 10.5045/br.2023.2022197
Background The clinical phenotype of hemophilia A (HA) does not always correlate with severity. Similarly, the presence of inhibitors does not necessarily increase the risk of bleeding. This paradox between clinical and laboratory... -
- CITED
-
- Close
- SHARE
-
- Close
